Aterian

Aterian Announces Reverse Stock Split

Retrieved on: 
Wednesday, March 20, 2024

NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) has announced a 1-for-12 reverse stock split of its common stock, effective with the market opening on Friday, March 22, 2024.

Key Points: 
  • NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) has announced a 1-for-12 reverse stock split of its common stock, effective with the market opening on Friday, March 22, 2024.
  • The reverse split was authorized by the Company's shareholders on August 11, 2023, granting the Company's Board of Directors (the "Board") the power to determine the timing and ratio of the split.
  • Consequently, every twelve shares of issued common stock will be combined into one share of common stock.
  • The reverse split will result in a new CUSIP number (02156U200) for the Company's common stock, which are expected to begin trading on a split-adjusted basis from March 22, 2024.

Aterian Makes Strategic Minority Equity Investment in 4th & Heart

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the recent closing of a strategic minority equity investment in 4th & Heart, the leading U.S. maker of premium ghee butter products.

Key Points: 
  • NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the recent closing of a strategic minority equity investment in 4th & Heart, the leading U.S. maker of premium ghee butter products.
  • The Company invested approximately $0.2 million in cash and approximately 145,000 shares of Aterian common stock.
  • Like Aterian’s other products, 4th & Heart pushes boundaries, and we’re excited to unlock future potential together,” said Max Dichter, 4th & Heart’s CEO.
  • To find 4th & Heart in a store near you please visit: 4th & Heart
    To find 4th & Heart on Amazon.com in the U.S., please visit: 4th & Heart on Amazon.com

Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference Call

Retrieved on: 
Thursday, February 29, 2024

ET that evening.

Key Points: 
  • ET that evening.
  • The conference call will be accessible by telephone and the internet.
  • Participants may also access the call through a live webcast at https://ir.aterian.io .
  • The archived online replay will be available for a limited time after the call in the investors section of the Aterian corporate website.

Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 Results

Retrieved on: 
Wednesday, February 14, 2024

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced a fixed cost reduction as part of the final steps of its previously announced SKU rationalization program. The Company also released certain preliminary fourth quarter 2023 results.

Key Points: 
  • The Company also released certain preliminary fourth quarter 2023 results.
  • The fixed cost reduction plan is expected to align the Company’s costs to what the Company believes will be the appropriate level as it drives towards adjusted EBITDA profitability in the second half of 2024.
  • The Company expects to primarily complete the plan by the end of the first quarter 2024 and to recognize and pay restructuring charges, primarily related to severance, of $0.9 million in such quarter.
  • The Company expects to report its final fourth quarter and fiscal year 2023 results on or about March 12, 2024.

Aterian Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 8, 2023

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2023. 

Key Points: 
  • NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2023.
  • Third quarter 2023 net revenue declined 40.2% to $39.7 million, compared to $66.3 million in the third quarter of 2022.
  • Third quarter 2023 operating loss of ($6.5) million decreased compared to a loss of ($108.9) million in the third quarter of 2022, an improvement of 94.0%.
  • Third quarter 2023 net loss of ($6.3) million decreased from a ($116.9) million loss in the third quarter of 2022, an improvement of 94.6%.

Vander-Bend Manufacturing and Subsidiaries Announce Strategic Transformation to Become One Company, with One Vision for the Future as Vantedge Medical

Retrieved on: 
Wednesday, November 8, 2023

For more than 40 years, Vander-Bend has been partnering with customers in complex precision manufacturing and assembly with differentiated engineering, prototyping support, and quality systems.

Key Points: 
  • For more than 40 years, Vander-Bend has been partnering with customers in complex precision manufacturing and assembly with differentiated engineering, prototyping support, and quality systems.
  • The Company primarily serves medical technology markets including Robotic Assisted Surgery and Radiation Oncology, among other high-growth end markets.
  • To offer a more streamlined and impactful customer experience, all five manufacturing companies will now unify under a single, cohesive brand – Vantedge Medical.
  • We couldn't be more enthusiastic about working alongside the team as one company, Vantedge Medical."

Aterian Sets Date for Third Quarter 2023 Earnings Announcement & Investor Conference Call

Retrieved on: 
Friday, October 27, 2023

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2023 financial results after the market close on Wednesday, November 8, 2023, and plans to host a conference call for investors and interested parties at 5:00 p.m.

Key Points: 
  • NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2023 financial results after the market close on Wednesday, November 8, 2023, and plans to host a conference call for investors and interested parties at 5:00 p.m.
  • The conference call will be accessible by telephone and the internet.
  • Participants may also access the call through a live webcast at https://ir.aterian.io.
  • The archived online replay will be available for a limited time after the call in the investors section of the Aterian corporate website.

Aterian Receives Extension To Regain Compliance With Nasdaq Minimum Bid Price Rule

Retrieved on: 
Tuesday, October 24, 2023

NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced that it received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company a 180-day extension, or until April 22, 2024, to regain compliance with Nasdaq’s $1.00 minimum bid price requirement as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule").

Key Points: 
  • NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced that it received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company a 180-day extension, or until April 22, 2024, to regain compliance with Nasdaq’s $1.00 minimum bid price requirement as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule").
  • The notification letter stated the Company would be afforded 180 calendar days from the date of the notification letter, or until October 23, 2023, to regain compliance with the Rule.
  • On October 13, 2023, the Company submitted to Nasdaq a request for an extension to comply with the Rule.
  • On October 24, 2023, Nasdaq provided the Notice stating it had determined that the Company was eligible under Nasdaq Listing Rule 5810(c)(3)(A) for an additional 180 calendar day period to regain compliance and confirmed the 180 day extension.

KANE ANNOUNCES ACQUISITION OF NET100

Retrieved on: 
Thursday, September 28, 2023

TRENTON, N.J., Sept. 28, 2023 /PRNewswire/ -- Kane Infrastructure Services Holdings, LLC ("Kane"), an Aterian Investment Partners ("Aterian") portfolio company, is pleased to announce the acquisition of NET100.

Key Points: 
  • TRENTON, N.J., Sept. 28, 2023 /PRNewswire/ -- Kane Infrastructure Services Holdings, LLC ("Kane"), an Aterian Investment Partners ("Aterian") portfolio company, is pleased to announce the acquisition of NET100.
  • For over 30 years, NET100 has been providing structured cabling and related technology systems services to leading customers in the public and private sector throughout the Mid-Atlantic.
  • Virginia is a very attractive geography for Kane, and we now have a contiguous operating footprint from New York to South Carolina," said Wozniak.
  • Bill Paris, vice president of NET100 stated, "We are excited to have found an acquiror that aligned with our strengths, resources, and expertise.

Aterian Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Thursday, September 7, 2023

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced management’s participation in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13 at the Lotte New York Palace Hotel in New York City.

Key Points: 
  • NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced management’s participation in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13 at the Lotte New York Palace Hotel in New York City.
  • The Company’s Co-Chief Executive Officers, Joe Risico and Arturo Rodriguez, will be available for one-on-one meetings with investors.
  • To schedule a meeting with Aterian’s management, please contact your conference representative or you may also email your request to [email protected].
  • To register for the conference, please contact your H.C. Wainwright representative or visit the conference website here .